Endosense raised €25M in a Series B round in Oct 2009. The company is based in Geneva, Switzerland. Investors in the round: GIMV, NeoMed, Ysios Capital. Data as of 6 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
